Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
4,238,270
-
Share change
-
-2,832,423
-
Total reported value
-
$12,814,000
-
Price per share
-
$3.01
-
Number of holders
-
14
-
Value change
-
-$8,129,564
-
Number of buys
-
10
-
Number of sells
-
7
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2016
As of 30 Sep 2016,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,238,270 shares.
The largest 10 holders included
NEA Management Company, LLC, Abingworth LLP, GOLDMAN SACHS GROUP INC, SG Americas Securities, LLC, Redmile Group, LLC, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Creative Planning, KCG Holdings, Inc., and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.